2023 Schedule D (Form 1040) (irs.gov) 2023 Form 8949

New Post Public Reply Private Reply Replies (0) Message Board
microcaps
720

2023 Schedule D (Form 1040) (irs.gov)

2023 Form 8949 (irs.gov)

broker statement showing cost basis and current market value

NNLX - Nanologix, Inc. | Overview | OTC Markets 
previously only those who met the qualifications of an expert trader- including  250 k net worth qualify to trade  I never understood how such would be implemented - brokers would resist determining whether a person is financially able to meet the conditions -but such requirements are apparently no longer required despite previous articles

https://blog.otcmarkets.com/2021/03/25/unders...-market/so any holder of such securities can still trade but limited actual blind trading means such stocks qualify as illiquid

Keep in mind that if a stock becomes completely worthless, you can claim a loss equal to your basis (what you paid for it) on your tax return. The stock is treated as though it had been sold on the last day of the tax year2.


NNLX - Nanologix, Inc. | Quote | OTC Markets
dont know how would be done this this year except by amended 1040 Sch D and 8949 etc or by an extension to file but what do you do if the stock is revived after you take the loss-another amended tax return?
can you take a loss on a stock which is now illiquid - Search (bing.com)

The OTC Markets Group Expert Market is a segment within the OTC (Over-the-Counter) Markets where certain publicly traded companies are listed. Let me provide you with some details:

Background:Most of the companies quoted on OTC Markets do not meet the minimum listing requirements for trading on a national securities exchange.These companies often do not file periodic reports or audited financial statements with the SEC, making it challenging for the public to find reliable information about them.Market Tiers:Companies quoted on the OTC Markets are divided into four tiers:OTCQX: The highest tier, with more stringent disclosure requirements.OTCQB: A middle tier with additional disclosure compared to the OTC Pink.OTC Pink: The most common tier, with varying levels of disclosure.Expert Market: The lowest level of disclosure among the OTC Market tiers.Expert Market Details:Companies listed on the Expert Market provide minimal disclosure compared to other tiers.

Trading on the Expert Market is limited to unsolicited quotations (customer orders).Securities quoted on the Expert Market are typically designated as “No Information” securities.
Investors cannot publicly sell their shares on this market, and bid/ask prices and trading volume information are not readily available.

Due to these restrictions, Expert Market shares are considered illiquid.
Recent Changes:On September 28, 2021, the SEC’s amendments to Rule 15c2-11 eliminated broker-dealer quotes for securities of issuers that fail to make current information publicly available.As a result, the OTC Markets Group Expert Market became the platform for broker-dealers to publish unsolicited quotes for “No Information” securities12.Copilot
2

Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 9

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 17

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 15

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 7

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 7

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 9

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 12

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Upcoming Earnings Announcements and Market Insights

Updated Category News Views 249

Companies Reporting Earnings Before The Market Opens Various companies are preparing for their quarterly earnings reports, each with expectations that could impact their stock performance in the market. For example, Bank of Hawaii is anticipated to report quarterly earnings of $1.05 per share on revenue of approximately $174.39 million. Similarly, Business First...

Continue Reading
Bloom Nutrition Unveils Bloom Pop: A Healthier Soda Choice

Updated Category News Views 425

Bloom Nutrition Introduces Bloom Pop Bloom Nutrition, the brand known for revolutionizing the wellness industry, has launched an exciting new product called Bloom Pop. This innovative soda is now available exclusively at Walmart, marking a significant step in the brand's journey towards making healthier options fun and accessible. A Bold and Bubbly Innovation Bloom Pop...

Continue Reading
Renault Surpasses Stellantis in European Car Market Growth

Updated Category News Views 502

Renault's Growth in the European Car Market Recent statistics reveal that new car sales in Europe showed a modest increase of 0.9% in 2024, primarily driven by a significant rise in hybrid vehicle registrations. This surge marks the fourth consecutive month where hybrid sales have surpassed those of petrol vehicles, indicating a pivotal shift in consumer preferences....

Continue Reading
Market Reactions Following Intense Presidential Debate Showdown

Updated Category News Views 91

Markets React to the Presidential Debate U.S. stock futures slipped and the dollar softened as investors watched a heated presidential debate reshape the political conversation. It was the first direct face-off between Republican candidate Donald Trump and Democratic Vice President Kamala Harris. Early reads from traders and analysts suggested Harris may have had the...

Continue Reading
Eli Lilly's Kisunla Gains Approval for Alzheimer's Treatment in UK

Updated Category News Views 81

Eli Lilly's Kisunla Gains Approval for Alzheimer's Treatment in the UK Eli Lilly and Company has recently celebrated a significant milestone with the approval of their innovative treatment, Kisunla™ (donanemab-azbt), for mild cognitive impairment and mild dementia associated with Alzheimer's disease. This groundbreaking therapy is specifically designed for adult...

Continue Reading